Home › Trial NCT07454226
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
- Trial IDNCT07454226
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorInstitute of Hematology & Blood Diseases Hospital, China
- Enrollment92
- Start date2026-05-30
- ConditionsPh-Like · Acute Lymphoblastic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.